Frontlight ResearchEarly access
Pulmonary arterial hypertension trials in Georgia
2 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleAn Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Where
- Tbilisi
- Age
- 18 years and over
- People
- 344 worldwide
- Run by
- Insmed Incorporated
See details and how to joinNCT07234032 · EU 2025-521769-29-00 - Phase 3Taking peopleEfficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Where
- Tbilisi
- Age
- 18 years and over
- People
- 344 worldwide
- Run by
- Insmed Incorporated
See details and how to joinNCT07179380 · EU 2025-521558-40-00